LNSR: LENSAR, Inc. - Summary | Jitta

LENSAR, Inc.

NASDAQ:LNSR

Price
$5.45
Loss Chance
48.6%
2.72JITTA SCORE
47.37%Under Jitta Line
Jitta Ranking
59 / 713
780 / 4,237
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (46)
Recent Business Performance (57)
Financial Strength (28)
Return to Shareholders (0)
Competitive Advantage (42)
Jitta Signs
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 20.98% in the last year
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.72
47.37%
3.03
> 1,000%
Health Care Equipment
5.83
38.37%
7.20
9.68%
7.26
59.23%
COMPANY DESCRIPTION
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.